{'fraction_non_alphanumeric': 0.03804347826086957, 'fraction_numerical': 0.02872670807453416, 'mean_word_length': 4.806306306306307, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Value of ~(18)F-FDG PET imaging for differentiation of benign and malignant pancreatic mass

To evaluate the value of positron emission tomography (PET) imaging with 18 F-FDG in differentiation of benign and malignent pancreatic mass. 12 patients with pancreatic occupying lesion diagnosed by ultra sond or CT/MR including 7 pancreatic cancer and 5 pancreatitis underwent 18 F-FDG PET imaging. Visual interpretation and semiquantitative analysis by calculating the tumor/liver ( T/L ) ratio based on ROI were performed on attenuation corrected images. 9 positive findings were detected. Among them, 7 were confirmed to be cancer, but the other 2 were mass-forming pancreatitis. Final diagnoses of the 3 patients with negative findings were confirmed to be pancreatitis. The mean T/L ratio was 2.58±0.95 in pancreatic cancer, significantly higher than that in pancreatitis (1.29±0.87) ( p =0.037). With a T/L ratio cutoff value of 1.5, all 7 cancer patients were correctly categorized. However, one pancreatitis had T/L ratio higher than 1.5. 18 F-FDG PET imaging was a potential reliable method in differentiating benign or malignant pancreatic mass with high negative predictive value, but the specificity was limited. Semiquantitative analysis may improve the accuracy of the diagnosis.